These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32999398)

  • 1. Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease.
    Badachhape AA; Working PK; Srivastava M; Bhandari P; Stupin IV; Devkota L; Tanifum EA; Annapragada AV; Ghaghada KB
    Sci Rep; 2020 Sep; 10(1):16185. PubMed ID: 32999398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
    Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR
    Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer's disease brains.
    Dudeffant C; Vandesquille M; Herbert K; Garin CM; Alves S; Blanchard V; Comoy EE; Petit F; Dhenain M
    Sci Rep; 2017 Jul; 7(1):4955. PubMed ID: 28694463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
    Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY
    Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in Alzheimer's disease.
    Ono M; Cheng Y; Kimura H; Watanabe H; Matsumura K; Yoshimura M; Iikuni S; Okamoto Y; Ihara M; Takahashi R; Saji H
    PLoS One; 2013; 8(9):e74104. PubMed ID: 24058519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
    Poduslo JF; Curran GL; Peterson JA; McCormick DJ; Fauq AH; Khan MA; Wengenack TM
    Biochemistry; 2004 May; 43(20):6064-75. PubMed ID: 15147190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
    Wadghiri YZ; Sigurdsson EM; Sadowski M; Elliott JI; Li Y; Scholtzova H; Tang CY; Aguinaldo G; Pappolla M; Duff K; Wisniewski T; Turnbull DH
    Magn Reson Med; 2003 Aug; 50(2):293-302. PubMed ID: 12876705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Metal-Free Method for Producing MRI Contrast at Amyloid-β.
    Hilt S; Tang T; Walton JH; Budamagunta M; Maezawa I; Kálai T; Hideg K; Singh V; Wulff H; Gong Q; Jin LW; Louie A; Voss JC
    J Alzheimers Dis; 2017; 55(4):1667-1681. PubMed ID: 27911291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (S)-[
    Alzghool OM; Rokka J; López-Picón FR; Snellman A; Helin JS; Okamura N; Solin O; Rinne JO; Haaparanta-Solin M
    Neuropharmacology; 2021 Sep; 196():108676. PubMed ID: 34216585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered dynamics of glymphatic flow in a mature-onset Tet-off APP mouse model of amyloidosis.
    Ben-Nejma IRH; Keliris AJ; Vanreusel V; Ponsaerts P; Van der Linden A; Keliris GA
    Alzheimers Res Ther; 2023 Jan; 15(1):23. PubMed ID: 36707887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.
    Sillerud LO; Solberg NO; Chamberlain R; Orlando RA; Heidrich JE; Brown DC; Brady CI; Vander Jagt TA; Garwood M; Vander Jagt DL
    J Alzheimers Dis; 2013; 34(2):349-65. PubMed ID: 23229079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging of amyloid plaques using hollow manganese oxide nanoparticles conjugated with antibody aβ1-40 in a transgenic mouse model.
    Kim JH; Ha TL; Im GH; Yang J; Seo SW; Lee IS; Lee JH
    Neuroreport; 2013 Jan; 24(1):16-21. PubMed ID: 23168564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.
    Okamura N; Suemoto T; Shimadzu H; Suzuki M; Shiomitsu T; Akatsu H; Yamamoto T; Staufenbiel M; Yanai K; Arai H; Sasaki H; Kudo Y; Sawada T
    J Neurosci; 2004 Mar; 24(10):2535-41. PubMed ID: 15014129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.
    Tanifum EA; Dasgupta I; Srivastava M; Bhavane RC; Sun L; Berridge J; Pourgarzham H; Kamath R; Espinosa G; Cook SC; Eriksen JL; Annapragada A
    PLoS One; 2012; 7(10):e48515. PubMed ID: 23119043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium-complexed Aβ-binding contrast agents for MRI diagnosis of Alzheimer's Disease.
    Matharu B; Spencer N; Howe F; Austen B
    Neuropeptides; 2015 Oct; 53():63-70. PubMed ID: 26234669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
    Petiet A; Santin M; Bertrand A; Wiggins CJ; Petit F; Houitte D; Hantraye P; Benavides J; Debeir T; Rooney T; Dhenain M
    Neurobiol Aging; 2012 Aug; 33(8):1533-44. PubMed ID: 21531045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques.
    Zhou FQ; Jiang J; Griffith CM; Patrylo PR; Cai H; Chu Y; Yan XX
    Alzheimers Res Ther; 2018 Apr; 10(1):40. PubMed ID: 29690919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.